HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Sexy” Probiotics By Vidazorb; Kendy-USA Goes Synbiotic With Actiflora+

This article was originally published in The Tan Sheet

Executive Summary

Vidazorblooks to make probiotics "joyful and sexy," while Kendy-USA extends its Actiflora line with a synbiotic Vcap version

You may also be interested in...



New Products In Brief

Alarm clock in a pill?: Rise-N-Shine's patent-pending Wake Up on Time supplement is formulated to "dissolve over time, so that it can deliver its benefits when you need them most - when the alarm clock rings," the year-old firm announces Aug. 7. The product contains a proprietary blend of B vitamins, amino acids, guarana seed and Siberian ginseng, and is "geared to address the psychological and physical reasons why people have trouble getting out of bed in the morning," Rise-N-Shine says. The supplement "does have one important side-effect - it promotes weight loss," founder Cathy Beggan notes in a press release. Currently, Beggan is developing a similar product that will also function as a sleep aid. Wake Up on Time is not available in stores yet, but can be purchased online for $29.95...

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel